Entera Bio Ltd (ENTX) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | - | - | - | - | - |
| Cost Of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
59.22%7.27 | 4.56 | 3.54 | 3.04 | 3.26 | |
| Selling, General, and Administrative | 26.61%0.16 | 0.12 | 0.13 | 0.05 | 0.12 |
| Research and Development | 53.86%4.93 | 3.20 | 2.25 | 1.72 | 1.64 |
| Operating Income/Loss | 59.22%-7.27 | -4.56 | -3.54 | -3.04 | -3.26 |
| Nonoperating Income/Loss | 203.09%-8.33 | -2.75 | 0.03 | 0.03 | 0.06 |
113.31%-15.60 | -7.31 | -3.51 | -3.02 | -3.20 | |
| Attributable To Parent | 113.31%-15.60 | -7.31 | -3.51 | -3.02 | -3.20 |
| Basic Average Shares | 187.56%145.08 | 50.45 | 47.76 | - | 47.09 |
| Diluted Average Shares | 187.56%145.08 | 50.45 | 47.76 | - | 47.09 |
| Basic Earnings Per Share | 21.43%0.11 | 0.14 | 0.07 | - | 0.07 |
| Diluted Earnings Per Share | 21.43%0.11 | 0.14 | 0.07 | - | 0.07 |